ng ml

Related by string. ng mL * NG . NGS . NGD . ngs . Ng . NGs . nger . Ngs . NGER : ko ng . ng ABS CBN . Ka Yan Ng . ng dL . Relax NG . Ng Weng Hoong . Katas ng VAT . ang ng . Cabinet NG . bei ng . Eileen Ng / MLD . mld . Ml . mls . MLs . Mls . MLER . MLS . ML . mL : mg mL . mg ml . Sierra Mist MLS . ml bottle . pg mL . pg ml . Mercedes Benz ML . Marxist Leninist CPI ML . MLS Supplemental Draft . copies mL . CPI ML * milliliter ng mL . milliliter ng ml *

Related by context. All words. (Click for frequent words.) 84 ng mL 78 nmol L 74 pg mL 73 nmol liter 72 pg ml 72 ng dL 72 nanograms per 70 mmol l 70 μmol L 69 mmol L 68 mg dL 68 #ng/ml 68 mg dl 68 μg L 68 g dL 67 mIU L 67 nmol L. 67 pmol L 66 hydroxyvitamin D levels 66 #.#ng/ml 66 serum concentrations 66 μg ml 66 serum TSH 65 μg dL 65 nmol 65 mL/min/#.# m 2 65 ng dl 65 serum testosterone 65 μg mL 65 nanograms milliliter 64 g dl 64 mU L 64 mEq L 64 nmol l 63 nM 63 mmol liter 63 tHcy 63 highest tertile 63 alanine aminotransferase ALT 63 serum calcium 63 transferrin saturation 63 μg liter 63 serum uric acid 63 HbA 1c 63 μg dl 63 mIU mL 63 mIU ml 63 mm Hg systolic 62 microg 62 PSA nadir 62 mcg mL 62 umol L 62 TT genotype 62 mcg dL 62 BLLs 62 mU liter 62 hydroxyvitamin D 62 μg 62 serum vitamin D 62 IU ml 61 ìg 61 log# copies mL 61 μg g 61 serum phosphorus 61 hypogonadal 61 serum potassium 61 alanine aminotransferase 61 μg d 61 mL/min/#.# m2 61 mg kg 61 elevated creatinine 61 #mg/dL [001] 61 mg d 61 elevated CRP 61 sUA 61 plasma concentrations 61 uM 61 lactate dehydrogenase LDH 61 serum IGF 61 euthyroid 61 mm Hg 61 x ULN 61 CK MB 61 #.#mmol L [002] 61 plasma folate 61 confidence interval CI 61 neutrophil counts 61 P = .# 61 μg l 60 % Confidence Interval 60 serum sodium 60 % CI #.#-#.# [003] 60 IU mL 60 glycated hemoglobin 60 mmol L. 60 #mmHg [001] 60 IGFBP 60 aspartate aminotransferase 60 #mmHg [002] 60 serum cortisol 60 baseline HbA1c 60 Hb A1C 60 ml kg 60 creatinine ratio 60 #.#/#.# mm Hg [003] 60 advanced adenomas 60 μM 60 pmol liter 60 #mg/dL [002] 60 copies ml 60 % CI #.#-#.# [006] 60 ug ml 60 thyroglobulin 60 lowest tertile 60 eosinophil count 60 glycosylated hemoglobin HbA1c 60 mmHg 60 Cmax 60 anti HBs 60 serum PTH 60 serum PSA 59 mmHg systolic 59 specific antigen PSA 59 ug mL 59 hsCRP levels 59 μg kg 59 cTnI 59 microalbuminuria 59 bioavailable testosterone 59 serum albumin 59 eGFR 59 mL min 59 -#.# mg dL [002] 59 #OHD levels 59 troponin T 59 hemoglobin Hb 59 serum creatinine levels 59 creatine kinase 59 creatinine clearance 59 mmHg diastolic 59 nanomolar 59 HGPIN 59 serum urate levels 59 serum phosphate 59 biochemical relapse 59 Plasma concentrations 59 kg/m2 59 PSADT 59 per deciliter mg 59 mCi 59 intact parathyroid hormone 59 albumin excretion 59 leukocyte count 59 hypokalemia 59 normal ULN 59 #mg/dl 59 glycated hemoglobin levels 59 HbA1c 59 plasma leptin 59 normotensive 59 hours postdose 59 isoprostane 59 glomerular filtration rate 59 sd = 59 serum HBV DNA 59 mm Hg diastolic 59 CrCl 59 serum retinol 58 serum glucose 58 thyroid stimulating hormone 58 MBq 58 albuminuria 58 hydroxy vitamin D 58 pg g 58 nonobese 58 alkaline phosphatase 58 ug kg 58 n = 58 nanograms 58 ug L 58 cortisol concentrations 58 protein excretion 58 plasma glucose levels 58 serum creatinine 58 PaO 2 58 urine albumin 58 homocysteine concentrations 58 creatinine 58 serum homocysteine 58 HbA1c levels 58 nondiabetics 58 serum ferritin 58 aminotransferase levels 58 fasting insulin 58 mg kg dose 58 thyroxine 58 osteopenic 58 neurodevelopmental impairment 58 aminotransferases 58 ACTH 58 cells uL 58 C reactive protein 58 aspartate aminotransferase AST 58 p = .# [002] 58 nanomoles per 58 hemoglobin A1c HbA1c 58 Serum creatinine 58 recurrent VTE 58 mol L 58 A1c levels 58 baseline Hb 58 lactate dehydrogenase 58 elevated LDH 57 cystatin C 57 advanced adenoma 57 SGPT 57 plasma uric acid 57 #.#mg/dL 57 D dimer 57 mcg dl 57 dehydroepiandrosterone sulfate 57 systolic BP 57 rheumatoid factor 57 per milliliter 57 mg kg bw 57 transaminases 57 OGTT 57 Hb levels 57 serum cholesterol 57 #OHD 57 plasma glucose 57 serum magnesium 57 serum urate 57 tPSA 57 mmol 57 biochemical recurrence 57 IGFBP 3 57 serum calcium levels 57 serum HCV RNA 57 micromolar 57 elevated ALT 57 elevated serum creatinine 57 HBeAg seroconversion 57 thyroid hormone levels 57 serum prostate 57 fasting blood glucose 57 prehypertensive 57 subclinical hypothyroidism 57 confidence interval #.#-#.# 57 antibody titer 57 nondiabetic 57 mL kg 57 HbA1C 57 CI = 57 CC genotype 57 LVEF 57 TIMP 57 mRNA expression 57 ALT elevation 57 mcg ml 57 copies mL 57 serum LDL cholesterol 57 estradiol 57 clomiphene 57 cholesterol LDL C 57 SHBG levels 57 serum CRP 57 Median survival 57 creatinine levels 57 serum folate 57 mg l 57 milliliter ng mL 57 hsCRP 56 A1C levels 56 lispro 56 glycosylated hemoglobin 56 preoperative PSA 56 micromoles 56 RBC folate 56 follicle stimulating hormone FSH 56 tertile 56 cGy 56 HbA 1c levels 56 #/#mmHg 56 adiponectin concentrations 56 glucuronide 56 ug dL 56 amprenavir 56 statistical significance p 56 mM 56 #μg [001] 56 ertapenem 56 Hb 56 ml min 56 ug dl 56 fasting glucose levels 56 LDL cholesterol levels 56 plasma HCV RNA 56 % CI #.#-#.# [002] 56 plasma homocysteine 56 MADRS score 56 % CI #.#-#.# [007] 56 airway responsiveness 56 CVD mortality 56 Hb A1c 56 mcg 56 ejection fractions 56 lymphocyte count 56 malondialdehyde 56 pT3 56 methylmalonic acid 56 intramuscularly 56 tertiles 56 heterozygotes 56 serum ALT 56 hematocrit 56 colorectal adenoma 56 urinary albumin 56 serum testosterone levels 56 pCi l 56 serum potassium levels 56 mU 56 Inhibin B 56 cTnT 56 mg dose 56 N telopeptide 56 p = #.# [002] 56 nondiabetic patients 56 urinary iodine 56 nonfasting triglyceride levels 56 lumbar spine BMD 56 peginterferon alfa 2a 56 serum phosphate levels 56 serum estradiol 56 MMSE score 56 antibody titers 56 inhibin B 56 urinary calcium 56 milliliter ng ml 56 fasting triglyceride levels 56 tHcy concentrations 56 X ULN 56 mg 56 asymptomatic carotid stenosis 56 elevated LDL cholesterol 56 urinary albumin excretion 56 serum triglyceride 56 plasma selenium 56 alpha1 56 posttreatment 56 urinary excretion 56 thyrotropin levels 56 kg m² 56 nonexposed 56 overt hypothyroidism 56 proteinuria 56 univariate analysis 56 hemoglobin concentrations 56 MIC# [001] 55 thyroid stimulating hormone TSH 55 55 MMSE scores 55 #mg/day [001] 55 urinary N telopeptide 55 vitamin D2 55 #.#mmol l [002] 55 Fasting glucose 55 CI -#.# 55 vasopressor 55 calcitriol 55 Prostate specific antigen 55 interquartile range 55 parous women 55 nonfatal MI 55 gastric pH 55 serum bilirubin 55 log# reduction 55 anemia hemoglobin 55 recurrent UTI 55 fasting plasma glucose FPG 55 d dimer 55 rs# [001] 55 corticosteroid dose 55 confidence intervals CIs 55 mg TID 55 plasma renin 55 5-FU/LV 55 log# 55 hs CRP 55 pCR 55 interleukin IL -6 55 HBV DNA levels 55 glycated hemoglobin HbA1c 55 serum phosphorus levels 55 MetS 55 mg/m2 dose 55 β blockers 55 AST ALT 55 % CI #.#-#.# [008] 55 abacavir lamivudine 55 subclinical hyperthyroidism 55 seropositivity 55 homozygotes 55 phthalate metabolites 55 femoral neck BMD 55 mcg kg 55 intima media thickness 55 mL sec 55 rs# [002] 55 flutamide 55 fluticasone salmeterol 55 serum IgE 55 mcg BID 55 gm dl 55 deciliter 55 PCa 55 kDa 55 neutrophil count 55 thyrotropin 55 serum lipid levels 55 coinfected 55 sUA levels 55 fasting glucose 55 primary aldosteronism 55 procalcitonin 55 8 OHdG 55 undetectable viral load 55 median PFS 55 NT proBNP 55 plasma urate 55 premenopausal 55 virologic failure 55 inhibitory concentration 55 Calcium intake 55 elevated uric acid 55 systolic dysfunction 55 statin monotherapy 55 kaempferol 55 HBeAg 55 GSTM1 55 μmol 55 min -1 55 mean baseline HbA1c 55 cardiac troponin T 55 fasting plasma glucose 55 polyp recurrence 55 hemoglobin A1C 55 milligrams deciliter 55 elevated homocysteine 55 dexamethasone 55 B7 H3 55 myeloperoxidase 54 dietary calcium intake 54 CR nPR 54 URTI 54 cardiovascular mortality 54 kcal d 54 invasive carcinomas 54 serum parathyroid hormone 54 TNFalpha 54 lymphocyte counts 54 leukopenia 54 androgen deprivation 54 HIV RNA 54 colorectal neoplasia 54 evaluable subjects 54 salmeterol fluticasone propionate 54 rapid virological response 54 HCV RNA 54 osmolality 54 adenoma 54 HCV replicon 54 fasting plasma 54 micrograms mcg 54 platelet aggregation 54 posttransplant 54 QTcF 54 paricalcitol 54 HER2 expression 54 seronegative 54 mEq 54 lignan intake 54 triacylglycerol concentrations 54 HOMA IR 54 exhaled nitric oxide 54 baseline LDH 54 ^ sup 54 fructosamine 54 dapagliflozin plus 54 pCi L 54 dietary folate 54 aged ≥ 54 NNRTI resistance 54 apolipoprotein B 54 iodixanol 54 cirrhotic 54 NOAEL 54 GSTT1 54 hypertensives 54 glulisine 54 p = 54 #mm Hg 54 triglyceride concentrations 54 lopinavir r 54 HDL2 54 iPTH 54 plasma pharmacokinetics 54 EBRT 54 pyridoxine 54 macroalbuminuria 54 -#.# ± [002] 54 hemoglobin concentration 54 erythrocyte sedimentation rate 54 NPH insulin 54 undetectable viral 54 oral allopurinol 54 hyperoxia 54 concomitant medications 54 carotid IMT 54 severe neutropenia 54 SCr 54 aminotransferase ALT 54 HER2 amplification 54 antigen PSA 54 plasma cortisol 54 symptomatic intracranial hemorrhage 54 achieved ACR# 54 Hazard Ratio 54 hip BMD 54 oral prednisone 54 fetuin 54 #mg doses [002] 54 immunoreactivity 54 inotropic 54 GH deficiency 54 creatine phosphokinase 54 rs# [003] 54 BENICAR HCT 54 undetectable HCV RNA 54 hydroxyvitamin D concentrations 54 glomerular filtration 54 onset diabetes mellitus 54 3mg 54 density lipoprotein cholesterol 54 serum thyroglobulin 54 micrograms 54 micrograms mL 54 serum selenium 54 basal cell nevus syndrome 54 antihypertensive medications 54 statistically significant p = 54 rs# [004] 54 hyperphenylalaninemia HPA due 54 #beta 54 lymph node metastasis 54 impaired fasting glucose 54 locoregional recurrence 54 EpCAM expression 54 SGOT 54 test OGTT 54 cells/mm3 54 HBeAg positive 54 highest quintile 54 IFN α 54 polycystic ovary syndrome PCOS 54 LV ejection fraction 54 PON1 enzyme 54 differentially expressed 54 oral glucose tolerance 54 elevated LDL 54 detectable HCV RNA 54 colorectal neoplasms 54 #mg/day [002] 54 airway hyper responsiveness 54 inflammatory markers 54 urinary oxalate 54 alanine transaminase 54 adiponectin levels 54 elevated troponin 54 HbA 1C 54 indinavir 54 HIV uninfected 54 ovarian carcinoma 54 intravesical therapy 54 calcium intakes 54 antithyroid 54 diastolic blood pressures 53 endometrial thickness 53 anti Mullerian hormone 53 periprocedural 53 nicardipine 53 corrected QT interval 53 noncarriers 53 % CI #.#-#.# [001] 53 systolic blood pressures 53 #ug [001] 53 oral antidiabetic medication 53 albumin excretion rate 53 elevated triglyceride levels 53 AUC0 53 circulating IGF 53 isoenzyme 53 P ≤ 53 % CI #.#-#.# [004] 53 Elevated serum 53 6 mercaptopurine 53 adjunctive placebo 53 imatinib therapy 53 mL 53 mu g 53 glycated 53 F FDG 53 vitamin D intakes 53 ergocalciferol 53 OADs 53 elevated TSH 53 certolizumab 53 #ug [002] 53 virologic response 53 urate levels 53 vertebral fracture 53 parasitaemia 53 clodronate 53 mg kg Hematide 53 folate intake 53 Cotinine 53 infliximab monotherapy 53 fructose diet 53 steroid dexamethasone 53 hepatocellular carcinomas 53 fosamprenavir 53 #mg/kg [002] 53 mcg dose 53 severe renal impairment 53 triiodothyronine 53 gestational hypertension 53 CHD mortality 53 preoperatively 53 NNT = 53 undetectable HBV DNA 53 #μg [002] 53 timepoints 53 T2DM 53 microalbumin 53 viremia 53 blood glucose concentrations 53 picograms 53 interferon alfa 2b 53 sFlt 1 53 #.#/#.# mmHg [001] 53 colorectal carcinoma 53 ± 53 moderate renal impairment 53 glucocorticoid 53 CYP#A# [002] 53 HNSCC 53 plasminogen activator inhibitor 53 kg -1 53 colorectal polyp 53 follicle stimulating hormone 53 antiandrogen 53 HIV HCV coinfected 53 baseline serum creatinine 53 ALT normalization 53 milliliters mL 53 plasma creatinine 53 thromboembolic events 53 mg kg -1 53 vitamin D metabolites 53 Homocysteine levels 53 Triglyceride levels 53 chlorthalidone 53 anovulatory 53 glycemia 53 oestradiol 53 hypercalcemia 53 prednisone prednisolone 53 adriamycin 53 adjunctive ABILIFY 53 HBsAg 53 elevated blood glucose 53 thyroxine T4 53 SUVmax 53 tibolone 53 vitamin K1 53 inhibitory concentrations 53 GnRH agonist 53 dose dependently 53 #.#mg/kg [002] 53 cfu 53 Index CDAI 53 DAS# [002] 53 advanced neoplasia 53 PCA3 scores 53 CI #.#-#.# [001] 53 GH secretion 53 mg BID 53 parathyroid hormone PTH 53 leptin concentrations 53 Apgar scores 53 transaminase 53 maintaining Hb 53 salivary cotinine 53 p ≤ 53 NNAL 53 CLA supplementation 53 p = #.# [004] 53 serum BDNF 53 loop diuretics 53 serum sodium concentration 53 HDL cholesterol concentrations 53 hematologic toxicity 53 endogenous EPO 53 nondepressed 53 ALT elevations 53 milligrams mg 53 5FU 53 plasma homocysteine levels 53 plasma glucose concentration 53 postop 53 antigen PSA levels 53 nonvertebral fractures 53 mg/m2 53 HCV genotype 53 KRAS mutations 53 diastolic BP 53 estrogen metabolites 53 HBeAg negative 53 tryptase 53 IFN alpha 53 REYATAZ r arm 53 perimenopausal women 53 transdermal estradiol 53 SHBG 53 placebo 53 urinary cortisol 53 mCi m 2 53 norethindrone 53 microalbumin test 53 histologically confirmed 53 PASI scores 53 breast carcinoma 53 HDL C 53 Hgb 53 COHb 53 PBMCs 53 Bq/m3 53 serum lactate 52 plasma triglycerides 52 hypophosphatemia 52 CIN2 + 52 triglyceride concentration 52 Peg IFN 52 bacteriuria 52 Serum concentrations 52 follicular fluid 52 pyrazinamide 52 ng g 52 lymphocytosis 52 IFN gamma 52 stone formers 52 carcinoembryonic antigen 52 hemoglobin A1c levels 52 tumor recurrence 52 abnormal lipid 52 -#.# log# 52 coronary stenosis 52 renal dysfunction 52 LAB GHRH 52 glucose tolerance test 52 mg orally 52 statistically significant p 52 prepubertal 52 left ventricular hypertrophy 52 hematopoietic cancers 52 serum triglycerides 52 peptide BNP 52 1ppm 52 #ppb [001] 52 mmol kg 52 TIMP 1 52 fasting triglycerides 52 A1Cs 52 glargine 52 #mg dose [002] 52 transaminase elevations 52 HI titers 52 nonfasting 52 dexamethasone Decadron 52 Orthostatic hypotension 52 serum phosphorous 52 metastatic prostate 52 TNF alpha IL 52 MSMB 52 triacylglycerol 52 RBP4 52 HBV DNA 52 CD4 counts 52 Baseline characteristics 52 Creatinine 52 p = NS 52 mitoxantrone 52 rizatriptan 52 prostate specific 52 concentration Cmax 52 acrylamide intake 52 cranial irradiation 52 mg m² 52 CDAI score 52 transaminase levels 52 thiazide diuretics 52 #mcg [003] 52 UGT#A# * 52 tamsulosin 52 triglycerides TG 52 elevated hsCRP 52 cells μL 52 mg calcium 52 comparator arm 52 tirofiban 52 metoprolol tartrate 52 angiotensin converting enzyme 52 aldosterone 52 #mg BID [003] 52 Prostate Specific Antigen PSA 52 chloride secretion 52 efavirenz EFV 52 mg/m2/day 52 mcg albinterferon alfa 2b 52 serum aminotransferase levels 52 fraction LVEF 52 urinary cadmium 52 IgM 52 gestational age 52 isoproterenol 52 mineral density 52 relapsed MM 52 ß carotene 52 abdominal adiposity 52 mm3 52 prolactin elevation 52 sinus rhythm 52 fluorouracil 52 irbesartan 52 lymph node involvement 52 radioimmunoassay 52 recurrent atrial fibrillation 52 postprandial insulin 52 natriuretic peptides 52 Wistar rats 52 cTnT levels 52 lanthanum carbonate 52 hematuria 52 blood Phe 52 per decilitre 52 milligrammes 52 rhEPO 52 sulphonylurea 52 52 mutated K ras 52 prolactin levels 52 carotid stenosis 52 PREMPRO 52 renal function 52 mg ml 52 hypoglycemic episodes 52 Pred Forte 52 E selectin 52 titers 52 plasma lipids 52 definite stent thrombosis 52 Elitek 52 gonadotropins 52 rCBF 52 clinically insignificant 52 monocyte chemoattractant protein 52 = #.#-#.# 52 PREZISTA r 52 Hazard Ratio HR 52 BMI ≥ 52 plus medroxyprogesterone acetate 52 Navelbine 52 evaluable 52 PRADAXA #mg 52 urate 52 progesterone receptor negative 52 salivary flow 52 adrenal function 52 Insulin sensitivity 52 initiating antiretroviral therapy 52 deoxy 52 nonpregnant women 52 prevalences 52 bilirubin levels 52 milligrams 52 histologic subtype 52 prostate cancer CaP 52 urinary BPA 52 52 prospectively randomized 52 adenoma recurrence 52 titrated glipizide 52 Hcy 52 nondrinkers 52 alpha carotene 52 QTc interval 52 hypercalciuria 52 QT QTc 52 adrenocorticotropic hormone 52 APOC3 52 CsA 52 Homocysteine 52 IL 1beta 52 IgA 52 recurrent wheezing 52 lipid lowering medications 52 hypogonadal men 52 viral load 52 myo inositol 52 hypocalcemia 52 cytarabine daunorubicin 52 oral antidiabetes 52 hepatic enzyme 52 folate vitamin B 52 poor metabolizers 52 reticulocytes 52 LDL C 52 asthma exacerbation 52 homocysteine levels 52 mcg Albuferon 52 elastase 52 estrogen receptor negative 52 distant metastasis 52 cirrhotic patients 52 PASI score 52 malondialdehyde MDA 52 doxorubicin docetaxel 52 penetrance 52 serum GGT 52 serum insulin 52 malignant polyps 51 FeNO 51 baseline A1C 51 tiotropium bromide 51 platelet reactivity 51 plasma renin activity 51 baseline FEV 51 bezafibrate 51 K DOQI 51 g l 51 mammographic density 51 microgram kg 51 insulin glargine 51 placebo p 51 apnea hypopnea index 51 benazepril 51 hemodilution 51 A1C 51 DAS# remission 51 μmol l 51 diabetes mellitus DM 51 gene polymorphism 51 antihypertensive therapy 51 IDDM 51 lopinavir r arm 51 LHRH agonists 51 epithelial ovarian cancer 51 VCAM 1 51 mg qd 51 posaconazole 51 seroprotection 51 AVODART 51 tipranavir r 51 subclinical 51 AUCs 51 HbA1C levels 51 invasive ductal 51 CK # plasma concentrations 51 PUFA 51 EDSS score 51 human chorionic gonadotropin hCG 51 NHANES III 51 platelet activation 51 Crohn Disease Activity 51 c reactive protein 51 binary restenosis 51 grade cervical intraepithelial 51 seropositive patients 51 nonresponders 51 #β estradiol 51 IgG antibody 51 PSA velocity 51 mg RDEA# 51 bFGF 51 pentoxifylline 51 reinfarction 51 retinol binding protein 51 cholesterols 51 atorvastatin #mg

Back to home page